• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液系统疾病中的CD4+CD25高表达FoxP3+调节性T细胞

CD4+CD25highFoxP3+ regulatory T-cells in hematologic diseases.

作者信息

Moon Hee-Won, Kim Bo Hyun, Park Chul Min, Hur Mina, Yun Yeo-Min, Kim Sung-Yong, Lee Mark Hong

机构信息

Department of Laboratory Medicine, Konkuk University School of Medicine, Hospital, 4-12 Hwayang-dong, Gwangjin-gu, Seoul, Korea.

出版信息

Korean J Lab Med. 2011 Oct;31(4):231-7. doi: 10.3343/kjlm.2011.31.4.231. Epub 2011 Oct 3.

DOI:10.3343/kjlm.2011.31.4.231
PMID:22016675
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3190000/
Abstract

BACKGROUND

CD4+CD25+ regulatory T-cells (Tregs) play a critical role in immune responses. We explored the status of Tregs in neoplastic and autoimmune hematologic diseases. We also evaluated the technical aspects of Treg measurement in terms of sample type and detection markers.

METHODS

A total of 68 subjects were enrolled: 11 with AML, 8 with MDS, 10 with autoimmune diseases, and 39 controls. Tregs were analyzed in peripheral blood (PB) and bone marrow (BM) samples from each subject. Flow cytometry and the Human Regulatory T cell Staining Kit (eBioscience, USA) for CD4, CD25, and FoxP3 (forkhead box P3) were used.

RESULTS

The CD4+CD25(high)/CD4 and CD4+CD25(high)FoxP3+/CD4 populations were significantly correlated (P<0.0001). The AML and high-risk MDS groups had significantly larger CD4+CD25(high)/CD4 and CD4+CD25(high)FoxP3+/CD4 populations in PB than the autoimmune (P=0.007 and 0.012, respectively) and control groups (P=0.004 and 0.006, respectively). Comparable findings were observed in BM. The CD4+CD25(high)FoxP3+/CD4 population was significantly larger in PB than in BM (P=0.0003).

CONCLUSIONS

This study provides comparison data for Tregs in AML, MDS, and autoimmune hematologic diseases, and would be helpful for understanding the different immunologic bases of various hematologic diseases. Treg measurement using CD4, CD25, and/or FoxP3 in PB rather than in BM seems to be practical for routine hematologic purposes. Large-scale analysis of the diagnostic role of Treg measurement is needed.

摘要

背景

CD4+CD25+调节性T细胞(Tregs)在免疫反应中起关键作用。我们探讨了Tregs在肿瘤性和自身免疫性血液疾病中的状态。我们还从样本类型和检测标志物方面评估了Treg测量的技术问题。

方法

共纳入68名受试者:11例急性髓系白血病(AML)患者、8例骨髓增生异常综合征(MDS)患者、10例自身免疫性疾病患者和39名对照者。对每个受试者的外周血(PB)和骨髓(BM)样本中的Tregs进行分析。使用流式细胞术和用于检测CD4、CD25和FoxP3(叉头框P3)的人类调节性T细胞染色试剂盒(美国eBioscience公司)。

结果

CD4+CD25(高表达)/CD4和CD4+CD25(高表达)FoxP3+/CD4群体显著相关(P<0.0001)。AML组和高危MDS组外周血中CD4+CD25(高表达)/CD4和CD4+CD25(高表达)FoxP3+/CD4群体显著大于自身免疫性疾病组(分别为P=0.007和0.012)和对照组(分别为P=0.004和0.006)。在骨髓中观察到类似结果。外周血中CD4+CD25(高表达)FoxP3+/CD4群体显著大于骨髓(P=0.0003)。

结论

本研究提供了AML、MDS和自身免疫性血液疾病中Tregs的比较数据,有助于理解各种血液疾病不同的免疫基础。在PB中而非BM中使用CD4、CD25和/或FoxP3测量Tregs似乎对常规血液学检查实用。需要对Treg测量的诊断作用进行大规模分析。

相似文献

1
CD4+CD25highFoxP3+ regulatory T-cells in hematologic diseases.血液系统疾病中的CD4+CD25高表达FoxP3+调节性T细胞
Korean J Lab Med. 2011 Oct;31(4):231-7. doi: 10.3343/kjlm.2011.31.4.231. Epub 2011 Oct 3.
2
Elevated frequencies of CD4⁺ CD25⁺ CD127lo regulatory T cells is associated to poor prognosis in patients with acute myeloid leukemia.CD4⁺ CD25⁺ CD127lo 调节性 T 细胞频率升高与急性髓系白血病患者预后不良相关。
Int J Cancer. 2011 Sep 15;129(6):1373-81. doi: 10.1002/ijc.25791. Epub 2011 Feb 26.
3
Low expressions of PD-L1 and CTLA-4 by induced CD4CD25 Foxp3 Tregs in patients with SLE and their correlation with the disease activity.SLE 患者诱导的 CD4CD25 Foxp3 Treg 细胞中 PD-L1 和 CTLA-4 的低表达及其与疾病活动的相关性。
Cytokine. 2020 Sep;133:155119. doi: 10.1016/j.cyto.2020.155119. Epub 2020 Jun 11.
4
Higher frequency of regulatory T cells in granulocyte colony-stimulating factor (G-CSF)-primed bone marrow grafts compared with G-CSF-primed peripheral blood grafts.与粒细胞集落刺激因子(G-CSF)预处理的外周血移植物相比,G-CSF预处理的骨髓移植物中调节性T细胞的频率更高。
J Transl Med. 2015 May 7;13:145. doi: 10.1186/s12967-015-0507-z.
5
Reduced frequency and functional defects of CD4CD25CD127 regulatory T cells in patients with unexplained recurrent spontaneous abortion.原因不明复发性自然流产患者中 CD4+CD25+CD127-调节性 T 细胞频率降低和功能缺陷。
Reprod Biol Endocrinol. 2020 Jun 10;18(1):62. doi: 10.1186/s12958-020-00619-7.
6
Detection of CD4+ CD25+ FOXP3+ regulatory T cells in peripheral blood of patients with chronic autoimmune urticaria.检测慢性自身免疫性荨麻疹患者外周血中的 CD4+ CD25+ FOXP3+ 调节性 T 细胞。
Australas J Dermatol. 2011 Aug;52(3):e15-8. doi: 10.1111/j.1440-0960.2010.00658.x. Epub 2010 Jun 28.
7
FOXP3 demethylation as a means of identifying quantitative defects in regulatory T cells in acute coronary syndrome.FOXP3 去甲基化作为鉴定急性冠脉综合征中调节性 T 细胞数量缺陷的一种方法。
Atherosclerosis. 2013 Jul;229(1):263-70. doi: 10.1016/j.atherosclerosis.2013.05.007. Epub 2013 May 16.
8
A modified flow cytometry method for objective estimation of human CD4 regulatory T cells (CD4 Tregs) in peripheral blood, via CD4/CD25/CD45RO/FoxP3 labeling.一种改良的流式细胞术方法,通过 CD4/CD25/CD45RO/FoxP3 标记,客观估计外周血中的人 CD4 调节性 T 细胞(CD4 Tregs)。
Cytometry B Clin Cytom. 2020 May;98(3):259-269. doi: 10.1002/cyto.b.21841. Epub 2019 Sep 30.
9
No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes.1型糖尿病中FOXP3 +调节性T细胞频率无改变。
Diabetes. 2007 Mar;56(3):604-12. doi: 10.2337/db06-1248.
10
Sirolimus did not affect CD4(+)CD25(high) forkhead box p3(+)T cells of peripheral blood in renal transplant recipients.西罗莫司对肾移植受者外周血中CD4(+)CD25(高表达)叉头框p3(+)T细胞无影响。
Transplant Proc. 2013 Jan-Feb;45(1):153-6. doi: 10.1016/j.transproceed.2012.07.145.

引用本文的文献

1
Increased IDO expression and regulatory T cells in acute myeloid leukemia: implications for immune escape and therapeutic targeting.急性髓系白血病中吲哚胺2,3-双加氧酶表达增加及调节性T细胞:对免疫逃逸和治疗靶点的影响
Blood Res. 2024 Dec 18;59(1):42. doi: 10.1007/s44313-024-00048-0.
2
High-expression of the innate-immune related gene UNC93B1 predicts inferior outcomes in acute myeloid leukemia.先天免疫相关基因UNC93B1的高表达预示急性髓系白血病预后较差。
Front Genet. 2023 Jan 18;14:1063227. doi: 10.3389/fgene.2023.1063227. eCollection 2023.
3
Regulatory T cells in pediatric AML are associated with disease load and their serial assessment suggests role in leukemogenesis.

本文引用的文献

1
Pillars Article: Control of Regulatory T Cell Development by the Transcription Factor Foxp3. Science 2003. 299: 1057-1061.支柱文章:转录因子Foxp3对调节性T细胞发育的控制。《科学》2003年。299卷:1057 - 1061页。
J Immunol. 2017 Feb 1;198(3):981-985.
2
Role of immune responses in the pathogenesis of low-risk MDS and high-risk MDS: implications for immunotherapy.免疫应答在低危 MDS 和高危 MDS 发病机制中的作用:免疫治疗的意义。
Br J Haematol. 2011 Jun;153(5):568-81. doi: 10.1111/j.1365-2141.2011.08683.x. Epub 2011 Apr 13.
3
ITP: Tregs come to the rescue.
儿童急性髓系白血病中的调节性T细胞与疾病负荷相关,对其进行连续评估提示其在白血病发生过程中发挥作用。
Am J Blood Res. 2020 Aug 25;10(4):90-96. eCollection 2020.
4
CD4CD25CD127FoxP Regulatory T-Cell Population in Acute Leukemias: A Review of the Literature.CD4CD25CD127FoxP 调节性 T 细胞在急性白血病中的研究进展:文献综述。
J Immunol Res. 2019 Mar 3;2019:2816498. doi: 10.1155/2019/2816498. eCollection 2019.
5
Role of regulatory T cells in acute myeloid leukemia patients undergoing relapse-preventive immunotherapy.调节性T细胞在接受预防复发免疫治疗的急性髓系白血病患者中的作用。
Cancer Immunol Immunother. 2017 Nov;66(11):1473-1484. doi: 10.1007/s00262-017-2040-9. Epub 2017 Jul 18.
6
Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.调节性细胞因子白细胞介素(IL)-35缓解Murphy Roths Large(MRL)/lpr小鼠的系统性红斑狼疮疾病活动
Clin Exp Immunol. 2015 Aug;181(2):253-66. doi: 10.1111/cei.12639.
7
FOXP3 and CTLA4 overexpression in multiple myeloma bone marrow as a sign of accumulation of CD4(+) T regulatory cells.多发性骨髓瘤骨髓中FOXP3和CTLA4的过表达作为CD4(+)调节性T细胞积聚的标志
Cancer Immunol Immunother. 2014 Nov;63(11):1189-97. doi: 10.1007/s00262-014-1589-9. Epub 2014 Aug 7.
8
Prognostic value of regulatory T cells in newly diagnosed chronic myeloid leukemia patients.调节性T细胞在新诊断慢性髓性白血病患者中的预后价值
Int J Clin Oncol. 2014 Aug;19(4):753-60. doi: 10.1007/s10147-013-0615-9. Epub 2013 Sep 26.
9
Influence of tumors on protective anti-tumor immunity and the effects of irradiation.肿瘤对保护性抗肿瘤免疫的影响及放疗的作用。
Front Oncol. 2013 Feb 1;3:14. doi: 10.3389/fonc.2013.00014. eCollection 2013.
10
Decreased levels of circulating CD4+CD25+Foxp3+ regulatory T cells in patients with primary antiphospholipid syndrome.原发性抗磷脂综合征患者循环中 CD4+CD25+Foxp3+调节性 T 细胞水平降低。
J Clin Immunol. 2013 May;33(4):876-9. doi: 10.1007/s10875-012-9857-y. Epub 2013 Jan 29.
Blood. 2010 Nov 25;116(22):4388-90. doi: 10.1182/blood-2010-09-302364.
4
T regulatory cells and their counterparts: masters of immune regulation.调节性T细胞及其对应细胞:免疫调节的掌控者。
Clin Exp Allergy. 2009 May;39(5):626-39. doi: 10.1111/j.1365-2222.2009.03242.x.
5
Increased frequency and suppression by regulatory T cells in patients with acute myelogenous leukemia.急性髓系白血病患者中调节性T细胞的频率增加及抑制作用
Clin Cancer Res. 2009 May 15;15(10):3325-32. doi: 10.1158/1078-0432.CCR-08-3010. Epub 2009 May 5.
6
Regulatory T cells and viral liver disease.调节性T细胞与病毒性肝病
J Viral Hepat. 2009 Apr;16(4):223-9. doi: 10.1111/j.1365-2893.2009.01081.x. Epub 2009 Feb 12.
7
CD4(+)CD25(+)FoxP3(+) regulatory T cells are increased whilst CD3(+)CD4(-)CD8(-)alphabetaTCR(+) Double Negative T cells are decreased in the peripheral blood of patients with multiple myeloma which correlates with disease burden.在多发性骨髓瘤患者的外周血中,CD4(+)CD25(+)FoxP3(+)调节性T细胞增加,而CD3(+)CD4(-)CD8(-)αβTCR(+)双阴性T细胞减少,这与疾病负担相关。
Br J Haematol. 2009 Mar;144(5):686-95. doi: 10.1111/j.1365-2141.2008.07530.x. Epub 2008 Dec 26.
8
Kinetics, function and bone marrow trafficking of CD4+CD25+FOXP3+ regulatory T cells in myelodysplastic syndromes (MDS).骨髓增生异常综合征(MDS)中CD4+CD25+FOXP3+调节性T细胞的动力学、功能及骨髓归巢
Leukemia. 2009 Mar;23(3):510-8. doi: 10.1038/leu.2008.333. Epub 2008 Nov 20.
9
Regulatory T cells and immune tolerance.调节性T细胞与免疫耐受。
Cell. 2008 May 30;133(5):775-87. doi: 10.1016/j.cell.2008.05.009.
10
Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura.慢性免疫性血小板减少性紫癜患者循环中CD25调节性T细胞存在缺陷。
Blood. 2008 Aug 15;112(4):1325-8. doi: 10.1182/blood-2008-01-135335. Epub 2008 Apr 17.